标题
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
作者
关键词
-
出版物
SEMINARS IN LIVER DISEASE
Volume -, Issue -, Pages -
出版商
Georg Thieme Verlag KG
发表日期
2021-07-08
DOI
10.1055/s-0041-1730927
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- On the proposed definition of metabolic associated fatty liver disease
- (2021) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- NAFLD as a metabolic disease in humans: A literature review
- (2021) Bertrand Cariou et al. DIABETES OBESITY & METABOLISM
- Management of non-alcoholic fatty liver disease
- (2021) Maria Letizia Petroni et al. BMJ-British Medical Journal
- Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH
- (2021) Sabine Daemen et al. Cell Reports
- Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease
- (2021) Oveis Jamialahmadi et al. GASTROENTEROLOGY
- Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
- (2021) Ramy Younes et al. GUT
- NIH's ‘precision nutrition’ bet aims for individualized diets
- (2021) Jocelyn Kaiser SCIENCE
- Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis
- (2021) Chloe Wong et al. Frontiers in Endocrinology
- Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
- (2021) Amedeo Lonardo et al. ADVANCES IN THERAPY
- Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles
- (2020) Alejandra Hernandez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease
- (2020) Bo Kyung Koo et al. Clinical Gastroenterology and Hepatology
- GENETICS AND EPIGENETICS IN THE CLINIC: PRECISION MEDICINE IN THE MANAGEMENT OF FATTY LIVER DISEASE
- (2020) Annalisa Cespiati et al. CURRENT PHARMACEUTICAL DESIGN
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- Mechanisms of Fibrosis Development in NASH
- (2020) Robert F. Schwabe et al. GASTROENTEROLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- Advances in non-invasive assessment of hepatic fibrosis
- (2020) Rohit Loomba et al. GUT
- Update on NAFLD genetics: from new variants to the clinic
- (2020) Eric Trépo et al. JOURNAL OF HEPATOLOGY
- Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011–2016
- (2020) M. H. Le et al. JOURNAL OF INTERNAL MEDICINE
- Effects of SGLT2 Inhibitors on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Meta‐Analysis of Randomized Controlled Trials
- (2020) Baodi Xing et al. Journal of Diabetes Investigation
- Women have Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
- (2020) Maya Balakrishnan et al. Clinical Gastroenterology and Hepatology
- Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology
- (2020) Silvia Sookoian et al. HEPATOLOGY
- Combined Effect of PNPLA3 , TM6SF2 , and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
- (2020) Helene Gellert-Kristensen et al. HEPATOLOGY
- Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping
- (2020) Zhipeng Liu et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
- (2020) Connor A. Emdin et al. PLoS Genetics
- Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
- (2020) Helen Jarvis et al. PLOS MEDICINE
- Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
- (2020) Amedeo Lonardo et al. Journal of Clinical Medicine
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- The Power of Single Cell Analysis for the Study of Liver Pathobiology
- (2020) Angela L. Chu et al. HEPATOLOGY
- Multiple Parallel Hits Hypothesis in NAFLD – Revisited After a Decade
- (2020) Herbert Tilg et al. HEPATOLOGY
- Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis
- (2020) Sophie Tran et al. IMMUNITY
- Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
- (2020) Feng‐Bin Lu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
- (2020) Leon A. Adams et al. SEMINARS IN LIVER DISEASE
- Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?
- (2020) David H Ipsen et al. Advances in Nutrition
- Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Juan Pablo Arab et al. Annals of Hepatology
- The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success
- (2020) Joost P.H. Drenth et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The PNPLA3-I148M variant confers an antiatherogenic lipid profile in insulin-resistant patients
- (2020) Panu K Luukkonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The times they are a-changin' (for NAFLD as well)
- (2020) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Sex and gender: modifiers of health, disease, and medicine
- (2020) Franck Mauvais-Jarvis et al. LANCET
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications
- (2020) Tiziana Fernández-Mincone et al. Expert Review of Gastroenterology & Hepatology
- Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
- (2020) Francisco Idalsoaga et al. Frontiers in Medicine
- Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
- (2020) Silvia Sookoian et al. Clinical and Molecular Hepatology
- Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease
- (2020) S.R. Sharpton et al. Cell Metabolism
- Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study
- (2020) Connor A. Emdin et al. GASTROENTEROLOGY
- AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Zobair M. Younossi et al. GASTROENTEROLOGY
- Precision medicine in the era of artificial intelligence: implications in chronic disease management
- (2020) Murugan Subramanian et al. Journal of Translational Medicine
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Experimental models of metabolic and alcoholic fatty liver disease
- (2020) Delfin Gerard Buyco et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metabolic drivers of non-alcoholic fatty liver disease
- (2020) Kendra K. Bence et al. Molecular Metabolism
- Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
- (2020) Manu V. Chakravarthy et al. Frontiers in Endocrinology
- Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
- (2020) Alessandro Mantovani et al. Metabolites
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- Genetics of Nonalcoholic Fatty Liver Disease: a 2018 Update.
- (2019) Luca VC Valenti et al. CURRENT PHARMACEUTICAL DESIGN
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
- (2019) Jingjing Cai et al. HEPATOLOGY
- NASH in Lean Individuals
- (2019) Ramy Younes et al. SEMINARS IN LIVER DISEASE
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis
- (2019) S. Pelusi et al. Clinical Gastroenterology and Hepatology
- Precision exercise medicine: understanding exercise response variability
- (2019) Robert Ross et al. BRITISH JOURNAL OF SPORTS MEDICINE
- Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
- (2019) Pegah Golabi et al. BMC GASTROENTEROLOGY
- Obstructive Sleep Apnea and the Liver
- (2019) Malav P. Parikh et al. Clinics in Liver Disease
- Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis
- (2019) Oliver Krenkel et al. GUT
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis
- (2019) Alexander Wree et al. SEMINARS IN LIVER DISEASE
- Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
- (2019) Daniel Lindén et al. Molecular Metabolism
- Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblastsin Liver Fibrosis
- (2019) Oliver Krenkel et al. Cells
- Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
- (2019) Javier Ampuero et al. Clinical Gastroenterology and Hepatology
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- High prevalence of non‐alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors
- (2019) C. Durán‐Vian et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
- (2019) José M Mato et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Concurrent nonalcoholic liver disease and type 2 diabetes: diagnostic and therapeutic considerations
- (2019) Marco Arrese et al. Expert Review of Gastroenterology & Hepatology
- Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
- (2019) Xuelian Xiong et al. MOLECULAR CELL
- NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
- (2019) Valerio Rosato et al. International Journal of Environmental Research and Public Health
- The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease
- (2019) James M. Paik et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
- (2019) Ross Dobie et al. Cell Reports
- Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives
- (2019) Juan P. Arab et al. HEPATOLOGY RESEARCH
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
- (2018) Juan Pablo Arab et al. Annual Review of Pathology-Mechanisms of Disease
- Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?
- (2018) R.B. Prussick et al. BRITISH JOURNAL OF DERMATOLOGY
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- The gut–liver axis and the intersection with the microbiome
- (2018) Anupriya Tripathi et al. Nature Reviews Gastroenterology & Hepatology
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis
- (2018) Feng-Bin Lu et al. Expert Review of Gastroenterology & Hepatology
- Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
- (2018) Huikuan Chu et al. GUT
- Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
- (2018) Omar A Mesarwi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2018) Zobair M. Younossi et al. TRANSPLANTATION
- Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
- (2018) David Porras et al. Frontiers in Physiology
- Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
- (2017) Cristina Alonso et al. GASTROENTEROLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
- (2017) Stefan Stender et al. NATURE GENETICS
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity
- (2017) Jun Chen et al. RADIOLOGY
- Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study
- (2016) E Voort et al. ACTA DERMATO-VENEREOLOGICA
- The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease
- (2016) Elliot B Tapper et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1
- (2016) Daniel Cabrera et al. DIGESTIVE DISEASES AND SCIENCES
- Innate Immunity and Inflammation in NAFLD/NASH
- (2016) Marco Arrese et al. DIGESTIVE DISEASES AND SCIENCES
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
- (2016) Sabina Paglialunga et al. Lipids in Health and Disease
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery
- (2016) Marcin Krawczyk et al. Surgery for Obesity and Related Diseases
- Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy
- (2015) Jeremy Lok Wei et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men
- (2015) Camilla Pramfalk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- Relationship Between Changes in Serum Levels of Keratin 18 and Changes in Liver Histology in Children and Adults With Nonalcoholic Fatty Liver Disease
- (2014) Raj Vuppalanchi et al. Clinical Gastroenterology and Hepatology
- Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
- (2014) Tom Luedde et al. GASTROENTEROLOGY
- PNPLA3gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease
- (2014) Jiayun Shen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis
- (2014) R. Candia et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Gender differences in weight loss; evidence from a NHS weight management service
- (2014) Manpal Singh Bhogal et al. PUBLIC HEALTH
- Nonalcoholic fatty liver disease and aging: Epidemiology to management
- (2014) Marco Bertolotti WORLD JOURNAL OF GASTROENTEROLOGY
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia
- (2013) Angelo B. Cefalù et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2013) Paul Angulo et al. GASTROENTEROLOGY
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
- (2013) Mazen Noureddin et al. HEPATOLOGY
- Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
- (2013) Ju Dong Yang et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
- (2013) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study
- (2013) Ella A.M. van der Voort et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- PNPLA3 I148M polymorphism and progressive liver disease
- (2013) Paola Dongiovanni WORLD JOURNAL OF GASTROENTEROLOGY
- Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
- (2012) Donghee Kim et al. HEPATOLOGY
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- PNPLA3 I148M polymorphism and liver damage in obese children
- (2011) Luca Valenti et al. JOURNAL OF PEDIATRICS
- Early Detection of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease by Using MR Elastography
- (2011) Jun Chen et al. RADIOLOGY
- Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
- (2011) Mattias Ekstedt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
- (2011) Elizabeth K. Speliotes et al. PLoS Genetics
- Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
- (2010) V. W.-S. Wong et al. GUT
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- (2010) S. McPherson et al. GUT
- Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
- (2010) Luca Valenti et al. HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- (2009) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started